According to the latest data from the Hong Kong Stock Exchange, Orient Securities sold 160,000 shares of REMEGEN on May 19 at an average price of HK$84.8306 per share, totaling approximately HK$13.57 million. Following this reduction, the firm's shareholding now stands at 10.3745 million shares, representing a 4.97% stake.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.